Verastem, Inc. — Director's Dealing 2012

Nov 2, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Verastem, Inc. (VSTM)
CIK: 0001526119
Period of Report: 2012-11-01

Reporting Person: Horobin Joanna (Chief Medical Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2012-11-01	Stock Option (Right to Buy)	$7.93	A	200000	Acquired	2022-10-31	Common Stock (200000)	Direct

Footnotes

F1: 25% of this option will vest on October 23, 2013 and then in equal quarterly installments until October 23, 2016.